| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2023 ( Subtotal = $3,290,649 ) |
| 2023 | 2023 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R35GM144237 | Understanding Ras effector switching and roles of Ras>RalGEF>Ral in development | 000 | 2 | NIH | 11/9/2022 | $337,219 |
| 2023 | 2023 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01HL145534 | Cardiac Myosin Binding Protein-C in Development and Reversal of Heart Failure | 000 | 5 | NIH | 12/12/2022 | $415,579 |
| 2023 | 2023 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | TA248950 | Primary Care Training and Enhancement - Residency Training in Mental and Behavioral Health | 00 | 1 | HRSA | 12/21/2022 | $499,999 |
| 2023 | 2023 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R21AI166688 | Type VII secretion in Streptococcus gallolyticus adherence | 000 | 1 | NIH | 11/14/2022 | $183,649 |
| 2023 | 2023 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | F30HL167457 | Metabolic Control of Epigenetic Reprogramming in Neovascularization | 000 | 1 | NIH | 1/13/2023 | $35,895 |
| 2023 | 2023 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01HL150124 | Epigenomic signaling and heart failure. | 000 | 4 | NIH | 11/17/2022 | $438,571 |
| 2023 | 2023 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R21NS121959 | Development and characterization of an AAV-based tool to functionally ablate astrocytic mitochondria in specific brain regions in vivo | 000 | 2 | NIH | 12/15/2022 | $189,375 |
| 2023 | 2023 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R21NS121945 | Investigating Pathophysiology of Glioma Stem Cells in 3D Bioprinted Vascularized Glioblastoma Model | 000 | 2 | NIH | 12/30/2022 | $166,285 |
| 2023 | 2023 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01DE031255 | Short-chain fatty acids and chronic temporomandibular joint pain | 000 | 2 | NIH | 12/20/2022 | $323,831 |
| 2023 | 2023 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | K08DE028593 | To define the novel roles of endochondrogenesis in mandible formation and trauma repair | 000 | 3 | NIH | 11/22/2022 | $117,860 |
| 2023 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01GM132443 | A novel mechanism of immunosuppression in sepsis: Depletion of monocytes and macrophages | 000 | 5 | NIH | 11/16/2022 | $0 |
| 2023 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | T9632499 | Advanced Nurse Education-Sexual Nurse Assault Examiner program | 01 | 5 | HRSA | 11/18/2022 | $0 |
| 2023 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01HL142640 | Inflammasome Activation Triggers Systemic Coagulation in Sepsis | 001 | 4 | NIH | 11/17/2022 | $278,084 |
| 2023 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | ASTWH220122 | Safe Mothers in Texas | 02 | 1 | DHHS/OS | 12/8/2022 | $0 |
| 2023 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | H7N45757 | Rural Communities Opioid Response Program-Psychostimulant Support | 01 | 1 | HRSA | 11/9/2022 | $0 |
| 2023 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | UG3NS128439 | Allosteric Targeting of Cannabinoid CB1 Receptor to Develop Non-Addictive Small Molecule Analgesics | 000 | 1 | NIH | 10/18/2022 | $0 |
| 2023 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | T1246108 | Grants to States to Support Oral Health Workforce Activities | 01 | 1 | HRSA | 11/8/2022 | $0 |
| 2023 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | K0245716 | Primary Care Medicine and Dentistry Clinician Educator Career Development Awards | 02 | 1 | HRSA | 10/26/2022 | $0 |
| 2023 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | UD737638 | Nurse Education, Practice, Quality, and Retention - Interprofessional Collborative Practice | 01 | 3 | HRSA | 11/18/2022 | $0 |
| 2023 | 2021 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | F30DK117538 | NFkb: Integrator of Host-Diet-Microbiota Interactions | 001 | 3 | NIH | 12/19/2022 | -$2,947 |
| 2023 | 2021 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | F30DK117538 | NFkb: Integrator of Host-Diet-Microbiota Interactions | 000 | 3 | NIH | 11/23/2022 | -$298 |
| 2023 | 2021 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01MH113574 | Glucocorticoid modulation of contextual processing and its neurocircuitry: Testing a new model of PTSD pathophysiology | 005 | 4 | NIH | 11/15/2022 | -$700,478 |
| 2023 | 2021 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01MH113574 | Glucocorticoid modulation of contextual processing and its neurocircuitry: Testing a new model of PTSD pathophysiology | 001 | 4 | NIH | 11/10/2022 | -$509,696 |
| 2023 | 2021 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01MH113574 | Glucocorticoid modulation of contextual processing and its neurocircuitry: Testing a new model of PTSD pathophysiology | 008 | 4 | NIH | 12/30/2022 | $1,210,489 |
| 2023 | 2021 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01ES028102 | The role of autophagy in cadmium induced prostate carcinogenesis | 001 | 5 | NIH | 1/5/2023 | $307,442 |
| 2023 | 2019 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R21DE027928 | Utilizing tissue clearing based 3-D imaging to quantitatively study neural regulation of craniofacial mesenchymal stem cells | 000 | 2 | NIH | 11/21/2022 | -$49 |
| 2023 | 2018 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | K02DE023551 | A new animal model for stress-induced transition from acute to chronic pain | 000 | 6 | NIH | 1/20/2023 | -$74 |
| 2023 | 2017 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | DP2AI136600 | Artificial Ecology Sink as prophylaxis against viral infection | 000 | 1 | NIH | 10/1/2022 | -$87 |
|
 | Issue Date FY: 2022 ( Subtotal = $50,368,871 ) (Continued on the next page) |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | U01NS117209 | Novel pediatric anticonvulsants for nerve agents | 001 | 3 | NIH | 8/31/2022 | $744,154 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R25DK126642 | Texas A&M College of Medicine Developing and Readying Underrepresented Minority Researchers (DRUMR) Summer Research Program | 000 | 3 | NIH | 8/9/2022 | $100,915 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01DE030081 | Functions of Family with Sequence Similarity 20 - Member C (FAM20C) andMember A (FAM20A) in Amelogenesis and Dentinogenesis | 000 | 3 | NIH | 8/16/2022 | $378,560 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | U01NS117278 | Novel Water-Soluble Adjunct Anticonvulsants for Nerve Agents | 001 | 3 | NIH | 9/1/2022 | $444,516 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01AA027768 | Ethanol drinking and the basal ganglia circuitry | 001 | 3 | NIH | 7/1/2022 | $334,961 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R35GM144237 | Understanding Ras effector switching and roles of Ras>RalGEF>Ral in development | 000 | 1 | NIH | 12/30/2021 | $374,881 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01AA027768 | Ethanol drinking and the basal ganglia circuitry | 000 | 3 | NIH | 3/31/2022 | $333,664 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | T32GM135115 | Diverse Predoctoral Training in Genetics | 001 | 3 | NIH | 6/1/2022 | -$4 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | T32GM135115 | Diverse Predoctoral Training in Genetics | 000 | 3 | NIH | 5/11/2022 | $167,997 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01AA028406 | Prenatal alcohol/cannabinoid co-exposures and fetal brain development | 002 | 3 | NIH | 4/30/2022 | $58,303 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01AA028406 | Prenatal alcohol/cannabinoid co-exposures and fetal brain development | 001 | 3 | NIH | 4/29/2022 | $477,513 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01AA028406 | Prenatal alcohol/cannabinoid co-exposures and fetal brain development | 000 | 2 | NIH | 3/3/2022 | $14,576 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R03AG070417 | Characterization of Alternative Polyadenylation in Alzheimer's Disease | 001 | 3 | NIH | 4/25/2022 | $15,150 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R03AG070417 | Characterization of Alternative Polyadenylation in Alzheimer's Disease | 000 | 3 | NIH | 1/24/2022 | $136,350 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01DC018403 | The taste of ribonucleosides: The molecular and cellular basis underlying chemosensory detection of previously unknown macronutrients | 000 | 3 | NIH | 5/17/2022 | $376,699 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01HL150124 | Epigenomic signaling and heart failure. | 001 | 3 | NIH | 6/8/2022 | $48,579 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01HL150124 | Epigenomic signaling and heart failure. | 000 | 3 | NIH | 11/17/2021 | $437,207 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01NS115809 | Identification of mechanisms by which cytisine and estrogen inhibit ER stress and exert neuroprotection in Parkinson's disease | 001 | 3 | NIH | 3/28/2022 | $35,226 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | R01NS115809 | Identification of mechanisms by which cytisine and estrogen inhibit ER stress and exert neuroprotection in Parkinson's disease | 000 | 3 | NIH | 2/15/2022 | $317,033 |
| 2022 | 2022 | TEXAS A&M UNIVERSITY SYSTEM, THE | 8441 RIVERSIDE PARKWAY BLDG 1 STE 3100 | BRYAN | TX | 77807 | BRAZOS | USA | F31DE029686 | Targeting Gut-Brain Axis Signaling to Treat Opioid Induced Hyperalgesia and Tolerance in Mice with Chronic Trigeminal Neuropathic Pain | 000 | 3 | NIH | 6/16/2022 | $36,728 |
|